|
ZNF397OS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.658500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.482500E-03 |
| Normal-vs-Stage2 |
3.087400E-01 |
| Normal-vs-Stage3 |
4.642300E-04 |
| Normal-vs-Stage4 |
4.045500E-02 |
| Stage1-vs-Stage2 |
5.484000E-01 |
| Stage1-vs-Stage3 |
8.904400E-02 |
| Stage1-vs-Stage4 |
1.827240E-01 |
| Stage2-vs-Stage3 |
7.856200E-02 |
| Stage2-vs-Stage4 |
1.599980E-01 |
| Stage3-vs-Stage4 |
8.126200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.059700E-02 |
| Normal-vs-AfricanAmerican |
5.003400E-03 |
| Normal-vs-Asian |
1.015380E-04 |
| Caucasian-vs-AfricanAmerican |
2.981000E-01 |
| Caucasian-vs-Asian |
2.259000E-03 |
| AfricanAmerican-vs-Asian |
6.794400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.204400E-03 |
| Normal-vs-Female |
8.281700E-02 |
| Male-vs-Female |
5.219600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.651840E-01 |
| Normal-vs-Extreme_Weight |
3.383300E-03 |
| Normal-vs-Obese |
3.135800E-02 |
| Normal-vs-Extreme_Obese |
6.121200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.297200E-01 |
| Normal_Weight-vs-Obese |
7.311400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.812400E-01 |
| Extreme_Weight-vs-Obese |
4.471800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.783200E-01 |
| Obese-vs-Extreme_Obese |
5.784800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.152410E-01 |
| Normal-vs-Age(41-60Yrs) |
1.904180E-01 |
| Normal-vs-Age(61-80Yrs) |
1.360190E-03 |
| Normal-vs-Age(81-100Yrs) |
1.567610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.225400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.296800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.550400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.744100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.483000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.614200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.351630E-01 |
| Normal-VS-Type2 PRCC |
1.13239999999237E-06 |
| Normal-VS-KIRP CIMP |
1.63639999999354E-05 |
| Normal-VS-Unclassified PRCC |
6.295800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.05289999999358E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.58759999999902E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.442800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.494590E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.134210E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.103720E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.357700E-03 |
| Normal-vs-N1 |
4.755900E-03 |
| Normal-vs-N2 |
4.661500E-03 |
| N0-vs-N1 |
4.613600E-01 |
| N0-vs-N2 |
3.567800E-01 |
| N1-vs-N2 |
2.887400E-01 |
|
|
